131 related articles for article (PubMed ID: 30416412)
1. Cost-Effectiveness of Voluntary HIV Testing Strategies in a Very Low-Prevalence Country, the Republic of Korea.
Lee YH; Bang JH; Park SM; Kang CR; Cho SI; Oh MD; Lee JK
J Korean Med Sci; 2018 Nov; 33(46):e304. PubMed ID: 30416412
[TBL] [Abstract][Full Text] [Related]
2. Reducing the cost of HIV antibody testing.
Tamashiro H; Maskill W; Emmanuel J; Fauquex A; Sato P; Heymann D
Lancet; 1993 Jul; 342(8863):87-90. PubMed ID: 8100916
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
4. Three-year outcome of rapid HIV testing at public health centers in Seoul, Republic of Korea: a short report.
Yang HJ; Kim J; Bang JH; Kang CR; Cho SI; Oh MD; Hwang ES; Lee JK
AIDS Care; 2021 Apr; 33(4):525-529. PubMed ID: 32279532
[TBL] [Abstract][Full Text] [Related]
5. Benefits of HIV screening of blood transfusions in Zambia.
Foster S; Buvé A
Lancet; 1995 Jul; 346(8969):225-7. PubMed ID: 7616804
[TBL] [Abstract][Full Text] [Related]
6. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
7. The impact of expected HIV transmission rates on the effectiveness and cost of ruling out HIV infection in infants.
Mrus JM; Yi MS; Eckman MH; Tsevat J
Med Decis Making; 2002; 22(5 Suppl):S38-44. PubMed ID: 12369230
[TBL] [Abstract][Full Text] [Related]
8. Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis.
Doyle NM; Levison JE; Gardner MO
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1280-5. PubMed ID: 16157152
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of pooled nucleic acid amplification testing for acute HIV infection after third-generation HIV antibody screening and rapid testing in the United States: a comparison of three public health settings.
Hutchinson AB; Patel P; Sansom SL; Farnham PG; Sullivan TJ; Bennett B; Kerndt PR; Bolan RK; Heffelfinger JD; Prabhu VS; Branson BM
PLoS Med; 2010 Sep; 7(9):e1000342. PubMed ID: 20927354
[TBL] [Abstract][Full Text] [Related]
10. Comparing the costs of HIV screening strategies and technologies in health-care settings.
Farnham PG; Hutchinson AB; Sansom SL; Branson BM
Public Health Rep; 2008; 123 Suppl 3(Suppl 3):51-62. PubMed ID: 19166089
[TBL] [Abstract][Full Text] [Related]
11. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
Gómez M
Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
[TBL] [Abstract][Full Text] [Related]
12. Performance and diagnostic usefulness of commercially available enzyme linked immunosorbent assay and rapid kits for detection of HIV, HBV and HCV in India.
Maity S; Nandi S; Biswas S; Sadhukhan SK; Saha MK
Virol J; 2012 Nov; 9():290. PubMed ID: 23181517
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India.
Venkatesh KK; Becker JE; Kumarasamy N; Nakamura YM; Mayer KH; Losina E; Swaminathan S; Flanigan TP; Walensky RP; Freedberg KA
PLoS One; 2013; 8(5):e64604. PubMed ID: 23741348
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a rapid human immunodeficiency virus test at two community clinics in Kwazulu-Natal.
Phili R; Vardas E
S Afr Med J; 2002 Oct; 92(10):818-21. PubMed ID: 12432808
[TBL] [Abstract][Full Text] [Related]
15. Screening for human immunodeficiency virus in physicians. Who should we test and what will it cost.
Levine AA; Sandler RS
N C Med J; 1994 Apr; 55(4):136-40. PubMed ID: 8008080
[No Abstract] [Full Text] [Related]
16. Costing analysis of an SMS-based intervention to promote HIV self-testing amongst truckers and sex workers in Kenya.
George G; Chetty T; Strauss M; Inoti S; Kinyanjui S; Mwai E; Romo ML; Oruko F; Odhiambo JO; Nyaga E; Mantell JE; Govender K; Kelvin EA
PLoS One; 2018; 13(7):e0197305. PubMed ID: 29979704
[TBL] [Abstract][Full Text] [Related]
17. The Cost and Cost-utility of Three Public Health HIV Case-finding Strategies: Evidence from Rhode Island, 2012-2014.
Li XC; Kusi L; Marak T; Bertrand T; Chan PA; Galárraga O
AIDS Behav; 2018 Nov; 22(11):3726-3733. PubMed ID: 29079947
[TBL] [Abstract][Full Text] [Related]
18. Who should be screened for HIV infection? A cost-effectiveness analysis.
McCarthy BD; Wong JB; Muñoz A; Sonnenberg FA
Arch Intern Med; 1993 May; 153(9):1107-16. PubMed ID: 8481077
[TBL] [Abstract][Full Text] [Related]
19. Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area.
Andersson S; da Silva Z; Norrgren H; Dias F; Biberfeld G
AIDS; 1997 Dec; 11(15):1815-22. PubMed ID: 9412699
[TBL] [Abstract][Full Text] [Related]
20. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
